Industry

Nationally ranked in eight specialties, three in the top 20 #2 Children’s Hospital in North Carolina CHAPEL HILL, N.C.–(BUSINESS WIRE)–#BestChildrensHospitals—UNC Children’s in Chapel Hill has been ranked among the nation’s top children’s hospitals, according to U.S. News & World Report’s “Best Children’s Hospitals” report released today. The hospital is nationally ranked in eight pediatric specialties … [Read more…]

Appointment helps the company expand its horizons across a broad range of insurance offerings and meet every customer’s needs FORT WASHINGTON, Pa.–(BUSINESS WIRE)–#HealthInsurance—Incenter Insurance Solutions, an innovative national insurance services provider delivering highly customized coverage plans, today announced the appointment of Matt Boyle as Vice President of their Health Solutions division. Mr. Boyle brings more … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “HPAPIs and Cytotoxic Drugs Manufacturing Market, by Drug Origin, by Manufacturing Location, by Drug Type, by Type of Pharmacological Molecule, by Application, and by Region – Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering. Highly potent active pharmaceutical ingredients (HPAPIs) have an increasingly significant share … [Read more…]

Prestigious industry accolade recognizes athenahealth’s refreshed branding effort to elevate its brand and highlight the company’s vision, culture, and commitment to innovation WATERTOWN, Mass.–(BUSINESS WIRE)–athenahealth, Inc., a leading provider of network-enabled software and services for medical groups and health systems nationwide, today announced the Software & Information Industry Association (SIIA) has named it the Marketing … [Read more…]

Data from the Accresa report showcase growing demand for subscription care benefits. DALLAS–(BUSINESS WIRE)–Accresa, a technology provider focused on healthcare payments solutions for employers and provider networks, has released a comprehensive benchmark report on the demand for subscription care amongst employers and employees covered under an employer-sponsored health plan. The report, compiled based on the … [Read more…]

MIAMI, Fla.–(BUSINESS WIRE)–Claims Development Management (CDM), a healthcare utilization management organization, established in 2013 and accredited in 2015 to deliver oversight to its clients under the National Committee for Quality Assurance (NCQA) https://www.ncqa.org guidelines, has earned its fourth Accreditation this May 3, 2022. This Recognition exemplifies CDM’s commitment to compliance and excellence in promoting high … [Read more…]

MENLO PARK, Calif.–(BUSINESS WIRE)–Deepcell, a life science company pioneering AI-powered cell classification and isolation for cell biology and translational research, today announced the appointment of Kevin Farrell as SVP, Operations. Kevin brings to Deepcell over 20 years of operations experience in leadership roles at life science companies, including Berkeley Lights and Standard Biotools (previously known … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “U.S. Long Term Care Market Size, Share & Trends Analysis Report by Service (Skilled Nursing Facility, Home Healthcare, Assisted Living Facilities, Hospice & Palliative Care and Others), and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering. The U.S. long term care market size is expected to reach USD 779.4 billion by … [Read more…]

CHICAGO–(BUSINESS WIRE)–The Society for Vascular Surgery® Vascular Quality Initiative® (SVS VQI), a nonprofit organization dedicated to improving the quality of vascular care within hospitals and outpatient facilities, announces that the Centers for Medicare and Medicaid Services (CMS) has expanded coverage for Transcarotid Artery Revascularization (TCAR) to include standard surgical risk patients within the VQI TCAR … [Read more…]

PRP Prevents Recurrence and Metastasis by Targeting and Eradicating Cancer Stem Cells MELBOURNE, Australia–(BUSINESS WIRE)–Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that the Company’s lead product candidate, PRP, targets solid tumors, which accounts for 80 – … [Read more…]